Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?
Effective treatment for chorioretinitis caused by congenital cytomegalovirus (CMV) infection remains unknown. We report an infant with congenital CMV infection, who required a 6-month course of antiviral therapy to control his chorioretinitis. Long-term treatment may be necessary for managing congenital CMV-associated chorioretinitis.
Shoji
Kensuke
K
Division of General Pediatrics, Department of Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
Ito
Naoki
N
Ito
Yushi
Y
Inoue
Naoki
N
Adachi
Shingo
S
Fujimaru
Takuya
T
Nakamura
Tomoo
T
Nishina
Sachiko
S
Azuma
Noriyuki
N
Saitoh
Akihiko
A
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002825:Chorioretinitis / Q000151:congenital* / Q000188:drug therapy*; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D015774:Ganciclovir